达沙替尼 - CAS:302962-49-8 - Shanghai Nataling Pharmaceutical Technology Co., Ltd.

Dasatinib

Item No.：	NLDP250002
CAS No.：	302962-49-8

Product Name	Dasatinib
Alias	DASATINIB;Dasatinib & its intermediates (R&D);Dasatinib & its intermediates;Dasatinib intermediate;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-...;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-;Dasatinib (anhydrous);Dasatinib (BMS-354825,Sprycel®);Dasatinib anhydrous;BMS354825;BMS-354825;Dasatinib Tablets;SYR472;Trelagliptin succinate;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;BMS 354825;MFCD11046566;N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide;FT-0650671;Dasatinib (BMS-354825);GTPL5678;CHEBI:49375;MLS006010904;BDBM13216;NCGC00181129-22;NCGC00181129-12;D5949;BMS 35482513;CAS-302962-49-8;DTXCID2020979;EX-A401;BCPP000263;NCGC00181129-03;AKOS015902363;NSC759877;Q-101345;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-;HMS2043N05;NSC-800087;MLS003915609;HMS3265C19;CS-0100;SR-00000000554-5;BMS-354825-03;HMS3244A06;BMS 345825;C22H26ClN7O2S;NCGC00181129-14;NCGC00181129-01;DASATINIB [WHO-DD];BMS Dasatinib;DTXCID50157977;302962-49-8 pound not863127-77-9;N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide;BRD-K49328571-001-07-7;DTXSID50235486;EN300-123025;DTXSID4040979;HY-10181;cid_3062316;NS00001968;anh. dasatinib;302962-49-8;ZBNZXTGUTAYRHI-UHFFFAOYSA-N;SCHEMBL8226;N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE;n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide;HMS3244A05;Q419940;D-3307;Pharmakon1600-01502275;HMS3244B05;HMS3654K05;NSC-759877;NCGC00181129-02;NSC-732517;AC-22749;BCB03_000715;NCGC00181129-07;5-Thiazolecarboxamide, monohydrate;Tox21_112736;dasatinib (anh.);HMS3744C11;2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide;DASATINIB [INN];DB01254;NSC800087;PA-3062316;s1021;CHEMBL1421;CCG-264779;UNII-RBZ1571X5H;X78UG0A0RN;UNII-X78UG0A0RN;SMR002529551;GS-6548;Kinome_3650;NSC 759877;SR-00000000554;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide;NCGC00481571-01;Tox21_112736_1;AB01273956-02;1N1;NCGC00181129-06;HMS3265C20;Sprycel;MLS004774145;Sprycel (Bristol Meyers);NCGC00181129-05;AB01273956_03;HMS3265D20;Dasatinib [USAN:INN];L01XE06;n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide;Dasatinib,BMS-354825;BCP9000589;BRD-K49328571-001-05-1;CHEBI:70839;...
CAS No.	302962-49-8
Molecular Formula	C22H26CLN7O2S
Molecular Weight	488.01
Density	1.4±0.1 g/cm3
Boiling Point	No data available